Influence of hormonal contraceptive methods and intrauterine devices on the prevalence of transmitted infections in young women

Authors

DOI:

https://doi.org/10.33448/rsd-v10i10.18642

Keywords:

Sexually Transmitted Diseases; Oral Hormonal Contraceptive; Intrauterine Device; Disease prevention.

Abstract

The objective of this study is to analyze how the use of hormonal contraceptive methods and intrauterine devices (IUD) can influence the use of barrier contraceptive methods, assessing whether there is an association with increased prevalence of sexually transmitted infections (STIs) in young women (aged 20 to 30 years).  Were analyzed medical records of the years 2018 and 2019 of the Specialized Center for Infectious and Parasitic Diseases (CEDIP) in Cascavel-PR, of women diagnosed with sexually transmitted infections that fit the specific age range. Most women diagnosed with STI use hormonal contraceptive or intrauterine device (58%). Of these women, only 45% make concomitant use of some barrier method and of these 59% use it irregularly. Thus, it was found that 81% of women with STIs do not use barrier condoms or use them incorrectly. Through inferential analyzes of the data obtained, it was possible to establish a hypothesis with a statistically significant value, that is, p<0.05, that women using barrier contraceptives contract less STIs than women who choose other contraceptive methods, such as hormonal contraceptives and IUD. This result supports the project's hypothesis that only the use of hormonal contraceptives or IUD does not protect against the spread of STIs.

References

Aguirrebengoa, O. A., Garcia, M. V., Sanchez, M. R., D’Elia, G., Méndez, B. C., Arrancudiaga, M. A., León, S. B., López, T. P., Escribano, P. C., Martín, J. B., Prieto, B. M., Fuentes, M. E., Lotero, M. G., Utrilla, M. R., Martín, C. R., & Del Romero Guerrero, J. (2020). Risk factors associated with sexually transmitted infections and HIV among adolescents in a reference clinic in Madrid. PLoS ONE, 15(3), 1–10. https://doi.org/10.1371/journal.pone.0228998

Apter, D. (2018). Contraception options: Aspects unique to adolescent and young adult. Best Practice and Research: Clinical Obstetrics and Gynaecology, 48(October), 115–127. https://doi.org/10.1016/j.bpobgyn.2017.09.010

Baeten, J. M., Nyange, P. M., Richardson, B. A., Lavreys, L., Chohan, B., Martin, H. L., Mandaliya, K., Ndinya-Achola, J. O., Bwayo, J. J., & Kreiss, J. K. (2001). Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. American Journal of Obstetrics and Gynecology, 185(2), 380–385. https://doi.org/10.1067/mob.2001.115862

Baldivia, G. C., & Graudenz, G. S. (2015). Typical case: Herpes zoster. Revista Da Associacao Medica Brasileira, 61(2), 114–115. https://doi.org/10.1590/1806-9282.61.02.114

Brasil. (2015). Biblioteca Virtual em Saúde.

Centers For Disease Control and Prevention. (2018). Sexually Transmitted Disease Surveillance 2018.

Centers For Disease Control and Prevention. (2015). Sexually Transmitted Diseases Treatment Guidelines, 2015 (Vol. 64). https://doi.org/10.1097/00008480-200308000-00006

Chan, P. A., Robinette, A., Montgomery, M., Almonte, A., Cu-Uvin, S., Lonks, J. R., Chapin, K. C., Kojic, E. M., & Hardy, E. J. (2016). Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature. Infectious Diseases in Obstetrics and Gynecology, 2016. https://doi.org/10.1155/2016/5758387

Colquitt, C. W., & Martin, T. S. (2017). Contraceptive Methods: A Review of Nonbarrier and Barrier Products. Journal of Pharmacy Practice, 30(1), 130–135. https://doi.org/10.1177/0897190015585751

Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013). Human papillomavirus and cervical cancer. The Lancet, 382(9895), 889–899. https://doi.org/10.1016/S0140-6736(13)60022-7

De Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012). Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. The Lancet Oncology, 13(6), 607–615. https://doi.org/10.1016/S1470-2045(12)70137-7

Decker, C. F. (2016). Sexually transmitted diseases: An overview. Disease-a-Month, 62(8), 258–259. https://doi.org/10.1016/j.disamonth.2016.03.008

Den Heijer, C. D. J., Hoebe, C. J. P. A., Driessen, J. H. M., Wolffs, P., Van Den Broek, I. V. F., Hoenderboom, B. M., Williams, R., De Vries, F., & Dukers-Muijrers, N. H. T. M. (2019). Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study among Primary Care Patients. Clinical Infectious Diseases, 69(9), 1517–1525. https://doi.org/10.1093/cid/ciz429

Dos Santos, M. M., Lopes, A. K. B., Roncalli, A. G., & De Lima, K. C. (2020). Trends of syphilis in Brazil: A growth portrait of the treponemic epidemic. PLoS ONE, 15(4), 1–11. https://doi.org/10.1371/journal.pone.0231029

Fuchs, W., & Brockmeyer, N. H. (2014). Sexually Transmitted Infections. Deutsche Dermatologische Gesellschaft, 12, 451–464. https://doi.org/10.1016/j.emc.2019.07.009

Gallo, M. F., Grimes, D. A., Lopez, L. M., & Schulz, K. F. (2013). Nonlatex versus latex male condoms for contraception. Cochrane Database of Systematic Reviews, 1. https://doi.org/10.1002/14651858.cd003550.pub2

Galvin, S. R., & Cohen, M. S. (2004). The role of sexually transmitted diseases in HIV transmission. Nature Reviews Microbiology, 2(1), 33–42. https://doi.org/10.1038/nrmicro794

Grandi, G., Barra, F., Ferrero, S., Sileo, F. G., Bertucci, E., Napolitano, A., & Facchinetti, F. (2019). Hormonal contraception in women with endometriosis: a systematic review. European Journal of Contraception and Reproductive Health Care, 24(1), 61–70. https://doi.org/10.1080/13625187.2018.1550576

Holmes, K. K., Levine, R., & Weaver, M. (2004). Effectiveness of condoms in preventing sexually transmitted infections. Bulletin of the World Health Organization, 82(6), 454–461. https://doi.org/10.1590/S0042-96862004000600012

Jung, M. (2019). Risk factors of sexually transmitted infections among female sex workers in Republic of Korea. Infectious Diseases of Poverty, 8(1), 1–8. https://doi.org/10.1186/s40249-019-0516-x

Kissinger, P., & Adamski, A. (2013). Trichomoniasis and HIV interactions: A review. Sexually Transmitted Infections, 89(6), 426–433. https://doi.org/10.1136/sextrans-2012-051005

Lago, T. D. G. do, Kalckmann, S., Alves, M. C. G. P., Escuder, M. M. L., Koyama, M., & Barbosa, R. M. (2020). Diferenciais da prática contraceptiva no Município de São Paulo, Brasil: resultados do inquérito populacional Ouvindo Mulheres. Cadernos de Saúde Pública, 36(10). https://doi.org/10.1590/0102-311x00096919

Mansour, D., Inki, P., & Gemzell-Danielsson, K. (2010). Efficacy of contraceptive methods: A review of the literature. European Journal of Contraception and Reproductive Health Care, 15(1), 4–16. https://doi.org/10.3109/13625180903427675

McCormack, D., & Koons, K. (2019). Sexually Transmitted Infections. Emergency Medicine Clinics of North America, 37(4), 725–738. https://doi.org/10.1016/j.emc.2019.07.009

Ministério da Saúde. (2020). Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis (IST).

Mishori, R., McClaskey, E. L., & Winklerprins, V. J. (2012). Chlamydia Trachomatis infections: Screening, diagnosis, and management. American Family Physician, 86(12), 1127–1132.

Mitchell, C., & Prabhu, M. (2013). Pelvic inflammatory disease: Current concepts in pathogenesis, diagnosis and treatment. Infectious Disease Clinics of North America, 27(4), 793–809. https://doi.org/10.1016/j.idc.2013.08.004

Organização Mundial da Saúde. (2019). Sexually transmitted infections (STIs).

Park, S. T., Lee, S. W., Kim, M. J., Kang, Y. M., Moon, H. M., & Rhim, C. C. (2017). Clinical characteristics of genital chlamydia infection in pelvic inflammatory disease. BMC Women’s Health, 17(1), 1–7. https://doi.org/10.1186/s12905-016-0356-9

Pereira A. S. et al. (2018). Metodologia da pesquisa científica. UFSM.

Petry, S., Padilha, M. I., Eich Kuhnen, A., & Horner Schlindwein Meirelles, B. (2019). Saberes de estudantes de enfermagem sobre a prevenção de Infecções Sexualmente Transmissíveis. Revista Brasileira de Enfermagem, 72(5), 1208–1216. http://search.ebscohost.com/login.aspx?direct=true&db= rzh&AN=138820234&site=ehost-live

Raidoo, S., & Kaneshiro, B. (2017). Contraception counseling for adolescents. Current Opinion in Obstetrics and Gynecology, 29(5), 310–315. https://doi.org/10.1097/GCO.0000000000000390

Rouzine, I. M. (2020). An evolutionary model of progression to aids. Microorganisms, 8(11), 1–15. https://doi.org/10.3390/microorganisms8111714

Sanjosé, S., Díaz, M., Castellsagué, X., Clifford, G., & Bruni, L. (2007). Worldwide prevalence and genotype distribution of cervical HPV in women with normal cytology. Lancet Infect, 7(7), 453–459. http://www.ncbi.nlm.nih.gov/pubmed/17597569

Serfaty, D. (2019). Update on the contraceptive contraindications. Journal of Gynecology Obstetrics and Human Reproduction, 48(5), 297–307. https://doi.org/10.1016/j.jogoh.2019.02.006

Vieira, E. M., Badiani, R., Dal Fabbro, A. L., & Rodrigues Junior, A. L. (2002). Características do uso de métodos anticoncepcionais no Estado de São Paulo. Revista de Saúde Pública, 36(3), 263–270. https://doi.org/10.1590/s0034-89102002000300002

Wagenlehner, F. M. E., Brockmeyer, N. H., Discher, T., Friese, K., & Wichelhaus, T. A. (2016). Klinik, Diagnostik und Therapie sexuell öbertragbarer Infektionen. Deutsches Arzteblatt International, 113(1–2), 11–22. https://doi.org/10.3238/arztebl.2016.0011

Published

07/08/2021

How to Cite

JACQUES, C. M. P. .; YONEGURA, W. H. T. .; SODRÉ, L. K. de A. . Influence of hormonal contraceptive methods and intrauterine devices on the prevalence of transmitted infections in young women. Research, Society and Development, [S. l.], v. 10, n. 10, p. e124101018642, 2021. DOI: 10.33448/rsd-v10i10.18642. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/18642. Acesso em: 24 oct. 2021.

Issue

Section

Health Sciences